Claudia Frey Mar 30 Cytosurge launches cell line engineering services based on proprietary FluidFM® technology by Claudia Frey | March 30, 2022 2502 Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more > Press Release Corporate FluidFM Applications Mar 30, 2022 Press Release
Claudia Frey Mar 07 Multiplexing Speeds up Writing and Editing DNA by Claudia Frey | March 7, 2022 1408 Labiotech.eu | While scientists can read DNA fast, editing and writing it is not that easy. Increasing the speed of editing and writing DNA sequences will be critical to ushering in new applications o... Read more > Press Clipping Mar 7, 2022
Claudia Frey Jan 18 R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisse by Claudia Frey | January 18, 2022 2241 Zurich | Cytosurge , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) at the Swiss Fe... Read more > Press Release Corporate FluidFM Applications Jan 18, 2022 Press Release
Katarina Svitek Jan 03 Mitochondria transplantation with FluidFM by Katarina Svitek | January 3, 2022 2865 Today, we are happy to introduce you to Christoph Gäbelein who developed a FluidFM-based approach to extract, inject and transplant organelles from and into living cells with subcellular spatial resol... Read more > Company Blog FluidFM Applications Jan 3, 2022
Claudia Frey Dec 22 Season's Greetings & Highlights in 2021 by Claudia Frey | December 22, 2021 2333 The past year has been a year of successful transformation and growth for us, even in these difficult times. Without your support and the great work of our employees, this would not have been possible... Read more > Company Blog Company Life Corporate Dec 22, 2021
Claudia Frey Aug 04 Partnership between Central Scientific Commerce and Cytosurge by Claudia Frey | August 4, 2021 2658 Zurich | We are delighted to announce our collaboration with CSC, a well-established and renowned Japanese organization specialized in the distribution of systems for life science research. Within thi... Read more > Press Release Corporate Aug 4, 2021 Press Release
Claudia Frey Mar 24 Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks by Claudia Frey | March 24, 2021 2494 Zurich | Cytosurge , a leading global provider for precision single cell manipulation , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate monoclo... Read more > Press Release Corporate FluidFM Applications Mar 24, 2021 Press Release
Paul Monnier Mar 08 FluidFM: A new approach to CRISPR gene editing by Paul Monnier | March 8, 2021 3499 With traditional delivery methods, such as lipofection or electroporation, the success of CRISPR-Cas mediated gene editing is often subpar due to poor cell viability and low transfection efficiency ra... Read more > Company Blog FluidFM Applications Mar 8, 2021
Claudia Frey Oct 01 Novel Approaches to Overcome CRISPR In Vitro Delivery Challenges by Claudia Frey | October 1, 2020 2900 EBR October 2020 | In order for CRISPR gene editing to reach its full potential, we must develop in vitro delivery approaches that will allow us to work with hard-to-transfect cells, large repair temp... Read more > Press Clipping FluidFM Applications Oct 1, 2020
Claudia Frey Jul 23 Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas by Claudia Frey | July 23, 2020 3116 Waltham, Mass. & Zurich | Olympus , a leading manufacturer of high-end research microscopes, and Cytosurge , a precision manufacturer of cell manipulation technologies, have entered a co-marketing agr... Read more > Press Release Corporate Jul 23, 2020 Press Release
Claudia Frey May 04 Harvard's Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editing by Claudia Frey | May 4, 2020 4158 Boston & Zurich | By Benjamin Boettner | Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG , a company manufacturing unique high-precision nanotech... Read more > Press Release Corporate FluidFM Applications May 4, 2020 Press Release
Pascal Behr Dec 19 10 Years Cytosurge by Pascal Behr | December 19, 2019 5823 “It all started with an idea, a great environment and two scientists dreaming of becoming their own bosses.” If I had to describe to you in one sentence, why Cytosurge was founded, this would probably... Read more > Company Blog Company Life Corporate Dec 19, 2019